---
audienceLevel: patient
cancerTypes:
- breast
- ovarian
citation: NCI, 2025
language: en
lastReviewed: '2025-12-30'
license: public_domain
reviewFrequency: quarterly
source: NCI
sourceType: 02_nci_core
status: active
tags:
- treatment
title: Cyclophosphamide - NCI
url: https://www.cancer.gov/about-cancer/treatment/drugs/cyclophosphamide
version: v1
---

# Cyclophosphamide - NCI

# Cyclophosphamide

Placeholder slot

(SY-kloh-FOS-fuh-mide)

Cyclophosphamide is a type of chemotherapy drug called an alkylating agent. In the body it gets converted into substances that bind to the DNA and stops it from being copied. This causes cells to die.

FDA Approved

Yes

[FDA label information for this drug is available at DailyMed.](https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=CYCLOPHOSPHAMIDE&pagesize=20&page=1&audience=consumer)

## Use in Cancer

Cyclophosphamide is approved to be used alone or with other [drugs](/Common/PopUps/popDefinition.aspx?id=348921&version=Patient&language=English) to treat:

- **[Acute lymphoblastic leukemia](/Common/PopUps/popDefinition.aspx?id=45586&version=Patient&language=English)** (ALL) in children.
- **Acute [monocytic](/Common/PopUps/popDefinition.aspx?id=46282&version=Patient&language=English) leukemia.**
- **[Acute myeloid leukemia](/Common/PopUps/popDefinition.aspx?id=46347&version=Patient&language=English)** (AML).
- **[Breast cancer](/Common/PopUps/popDefinition.aspx?id=444971&version=Patient&language=English).**
- **[Chronic granulocytic leukemia](/Common/PopUps/popDefinition.aspx?id=46754&version=Patient&language=English).**
- **[Chronic lymphocytic leukemia](/Common/PopUps/popDefinition.aspx?id=44846&version=Patient&language=English)** (CLL).
- **[Chronic myelogenous leukemia](/Common/PopUps/popDefinition.aspx?id=44901&version=Patient&language=English)** (CML).
- **[Hodgkin lymphoma](/Common/PopUps/popDefinition.aspx?id=270800&version=Patient&language=English).** It is used in patients with [stage III](/Common/PopUps/popDefinition.aspx?id=45896&version=Patient&language=English) or [stage IV](/Common/PopUps/popDefinition.aspx?id=45898&version=Patient&language=English) disease.
- **[Multiple myeloma](/Common/PopUps/popDefinition.aspx?id=45793&version=Patient&language=English).**
- **[Mycosis fungoides](/Common/PopUps/popDefinition.aspx?id=45794&version=Patient&language=English)** (a type of [cutaneous T-cell lymphoma](/Common/PopUps/popDefinition.aspx?id=46771&version=Patient&language=English)) that is [advanced](/Common/PopUps/popDefinition.aspx?id=478743&version=Patient&language=English).
- **[Neuroblastoma](/Common/PopUps/popDefinition.aspx?id=45418&version=Patient&language=English)** that is [disseminated](/Common/PopUps/popDefinition.aspx?id=44278&version=Patient&language=English).
- **[Non-Hodgkin lymphoma](/Common/PopUps/popDefinition.aspx?id=45148&version=Patient&language=English)** (NHL). It is used in patients with [stage III](/Common/PopUps/popDefinition.aspx?id=45908&version=Patient&language=English) or [stage IV](/Common/PopUps/popDefinition.aspx?id=45909&version=Patient&language=English) NHL, including the following types:
- [Lymphocytic](/Common/PopUps/popDefinition.aspx?id=46301&version=Patient&language=English) lymphoma (nodular or diffuse).
- Mixed-cell type lymphoma.
- [Histiocytic lymphoma](/Common/PopUps/popDefinition.aspx?id=373019&version=Patient&language=English).
- [Burkitt lymphoma](/Common/PopUps/popDefinition.aspx?id=45203&version=Patient&language=English).
- **[Ovarian cancer](/Common/PopUps/popDefinition.aspx?id=445074&version=Patient&language=English).**
- **[Retinoblastoma](/Common/PopUps/popDefinition.aspx?id=46774&version=Patient&language=English).**

Cyclophosphamide is also being studied in the treatment of other types of [cancer](/Common/PopUps/popDefinition.aspx?id=45333&version=Patient&language=English).

## More About Cyclophosphamide

[Definition from the NCI Drug Dictionary](https://www.cancer.gov/publications/dictionaries/cancer-drug/def/39748) - Detailed scientific definition and other names for this drug.

MedlinePlus Information on [Cyclophosphamide Injection](https://medlineplus.gov/druginfo/meds/a611044.html) and [Cyclophosphamide Tablet](https://medlineplus.gov/druginfo/meds/a682080.html) - Lay language summaries of important information about these drugs. MedlinePlus information may include the following:

- warnings about the drug,
- what the drug is used for and how it is used,
- what you should tell your doctor before using the drug,
- what you should know about the drug before using it,
- other drugs that may interact with the drug, and
- possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

## Clinical Trials Accepting Patients

[Find Clinical Trials for Cyclophosphamide](https://www.cancer.gov/research/participate/clinical-trials/intervention/C405) - Check for trials from NCI's list of cancer clinical trials now accepting patients.
